4
Changes in Ownership
Harmony Biosciences Holdings, Inc. Filed Acc 0001677141-25-000008
CHIEF FINANCIAL OFFICER sold 20,000 shares at $39.54 ($790,896)
- CHIEF FINANCIAL OFFICER acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kapadia Sandip · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +20,000 | $29.03 | $580,600 | 20,000 | D |
| 2025-12-05 | Sale : show line 2 in the form 10b5-1 | −20,000 | $39.54 | $790,896 | 0 | D |
| Open-market sales · 20,000 sh · avg $39.54 · $790,896 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-05 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option | −20,000 | 185,000 | D |
Loading xslF345X05/form4-12092025_041201.xml…